May 3, 2024
Lymphocyte Antigen 6 (Ly6) Targeted Cancer Immunotherapy
Lymphocyte Antigen 6 (Ly6) Targeted Cancer Immunotherapy
Technology is related to using antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) transduced immune cells that selectively targets Ly6 family of proteins overexpressed in cancer...